Natella Y. Rakhmanina
Pediatric Infectious Disease
111 Michigan Avenue Northwest
Washington, DC 20010
Washington, DC 20010
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Letter: Contraception and Relevant Health Outcomes Among Adolescent Girls and Young Women with HIV: A Cohort Study of Urban Youth in the United States.
Journal: AIDS patient care and STDs
Published: August 25, 2026
Birth and Infant Growth Outcomes Following Prenatal Exposure to Bictegravir.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 26, 2026
Long-Acting Injectable Antiretroviral Therapies for HIV Treatment and Prevention: Clinical Pharmacology, Recent Advances and Future Opportunities.
Journal: Journal of clinical pharmacology
Published: May 02, 2026
Response to van Rooij et al., "Clinical Context and Comparative Interpretation of Dermatologic Disease Burden in People With HIV in the Modern Antiretroviral Era".
Journal: Journal of the American Academy of Dermatology
Published: April 29, 2026
Clarification to HIVMA/IDSA HIV Primary Care Guidance Immunization Recommendations.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 19, 2026
Building Successful Career Trajectories for Early-Stage Investigators in HIV Research: Reflections from the DC CFAR My Path to Independence Series.
Journal: AIDS research and human retroviruses
Published: February 18, 2026
Expanding Evidence on Pediatric Outcomes of Integrase Strand Transfer Inhibitor Use in Pregnancy.
Journal: JAMA network open
Published: November 26, 2025
Off-label dosing of long-acting injectable cabotegravir and rilpivirine during pregnancy: A case study with therapeutic drug monitoring.
Journal: British journal of clinical pharmacology
Published: October 04, 2025
Reimagining Paediatric HIV Care: Centering Infants and Young Children in Optimized, Integrated Models of Care.
Journal: Journal of the International AIDS Society
Published: September 02, 2025
Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC.
Journal: Journal of the American Academy of Dermatology
Published: June 13, 2025
Acceptability, Facilitators, and Barriers of Long-Acting Injectable Cabotegravir/Rilpivirine Among Youth With HIV in the United States.
Journal: The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Published: February 10, 2025
Transient Viremia Among People with HIV Receiving Injectable Cabotegravir Plus Rilpivirine.
Journal: AIDS research and human retroviruses
Published: February 03, 2025
Last Updated: 09/26/2026